BIORESTORATIVE THERAPIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 29.25K shares.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-12-31 was 0.00 shares.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-09-30 was 0.00 shares.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-06-30 was 0.00 shares.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 29.25K shares.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 0.00 shares.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was 0.00 shares.
- BIORESTORATIVE THERAPIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 29.25K shares 10-K · filed 2026-03-26 | |
| 2025-03-31 | 29.25K shares 10-Q · filed 2025-05-14 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 0.00 shares 10-K · filed 2016-03-30 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | 0.00 shares derived: sum of 4 quarters · filed 2015-11-23 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2015-08-14 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-15 | 0.00 shares derived: sum of 4 quarters · filed 2015-05-15 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | 0.00 shares 10-K · filed 2015-03-31 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-31 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | 0.00 shares 10-K · filed 2015-03-31 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | 0.00 shares derived: sum of 4 quarters · filed 2014-04-11 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-15 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | 0.00 shares 10-K · filed 2014-04-11 |
| 2011-12-31 | 0.00 shares 10-K · filed 2013-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |